These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9782069)

  • 1. Pharmacological profiles of SKP-450 and its family, a K+ channel opener, in comparison with levcromakalim.
    Hong KW; Shin HS; Kim CD; Shin YW; Yoo Se
    Pharmacol Res; 1998 Sep; 38(3):191-7. PubMed ID: 9782069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular pharmacology of SKP-450, a new potassium channel activator, and its major metabolites SKP-818 and SKP-310.
    Shin HS; Seo HW; Yoo SE; Lee BH
    Pharmacology; 1998 Mar; 56(3):111-24. PubMed ID: 9532610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effects of the novel potassium channel activator SKP-450 and its major metabolites in rats.
    Shin HS; Seo HW; Oh JH; Lee BH
    Arzneimittelforschung; 1998 Oct; 48(10):969-78. PubMed ID: 9825113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antihypertensive and cardioprotective effects of (-)-MJ-451, an ATP-sensitive K(+) channel opener.
    Lee YM; Yen MH; Peng YY; Sheu JR; Chen YC; Chang MJ; Cheng CY
    Eur J Pharmacol; 2000 May; 397(1):151-60. PubMed ID: 10844109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the vascular relaxant effects of ATP-dependent K+ channel openers on aorta and pulmonary artery isolated from spontaneously hypertensive and Wistar-Kyoto rats.
    Kwan YW; To KW; Lau WM; Tsang SH
    Eur J Pharmacol; 1999 Jan; 365(2-3):241-51. PubMed ID: 9988108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic profile of SKP-450, a new potassium-channel activator.
    Lee BH; Yoo SE; Shin HS
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):85-94. PubMed ID: 9456282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of KRN4884, a novel K channel opener, on the cardiovascular system in anesthetized dogs: a comparison with levcromakalim, nilvadipine, and nifedipine.
    Izumi H; Jinno Y; Kaneta S; Tanaka Y; Okada Y; Izawa T; Ogawa N
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):189-97. PubMed ID: 7475042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP-sensitive potassium-channel-opening activity of CL-065, a 3-[(substituted-carbonyl)amino]-2H-1-benzopyran, in the rat.
    Chen MJ; Lee YM; Sheu JR; Hu CT; Yen MH
    J Pharm Pharmacol; 1998 Jan; 50(1):83-90. PubMed ID: 9504439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
    Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
    Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal nitric oxide release differentially modulates vasodilations by pinacidil and levcromakalim in goat coronary artery.
    Deka DK; Raviprakash V; Mishra SK
    Eur J Pharmacol; 1998 May; 348(1):11-23. PubMed ID: 9650826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
    McPherson GA; Stork AP
    Br J Pharmacol; 1992 Jan; 105(1):51-8. PubMed ID: 1534504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle.
    Perez-Vizcaino F; Casis O; Rodriguez R; Gomez LA; Garcia Rafanell J; Tamargo J
    Br J Pharmacol; 1993 Nov; 110(3):1165-71. PubMed ID: 8298804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ba2+ differentially inhibits the Rb+ efflux promoting and the vasorelaxant effects of levcromakalim and minoxidil sulfate in rat isolated aorta.
    Quast U; Baumlin Y; Loffler C
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 353(1):86-93. PubMed ID: 8750921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasodilating actions of cromakalim in resting and contracting states of carotid arteries from spontaneously hypertensive rats.
    Asano M; Masuzawa-Ito K; Matsuda T
    Eur J Pharmacol; 1994 Sep; 263(1-2):121-31. PubMed ID: 7529710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The individual enantiomers of cis-cromakalim possess K+ channel opening activity.
    Quast U; Villhauer EB
    Eur J Pharmacol; 1993 Apr; 245(2):165-71. PubMed ID: 8491256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of rubidium on responses to potassium channel openers in rat isolated aorta.
    Greenwood IA; Weston AH
    Br J Pharmacol; 1993 Aug; 109(4):925-32. PubMed ID: 8401946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective effects of KR-30450, a novel K+(ATP) opener, and its major metabolite KR-30818 on isolated rat hearts.
    Jung YS; Moon CH; Cho TS; Yoo SE; Shin HS
    Jpn J Pharmacol; 1998 Jan; 76(1):65-73. PubMed ID: 9517406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cromakalim-induced relaxation of potassium precontracted rabbit, cat, and rat isolated cerebral arteries.
    Parsons AA; Ksoll E; Mackert JR; Schilling L; Wahl M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):384-92. PubMed ID: 1906583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potassium channel-opening and vasorelaxant profiles of a novel compound YM099 in rat isolated portal vein and rabbit isolated aorta.
    Uchida W; Hirano Y; Shirai Y; Taguchi T; Masuda N; Shibasaki K; Hirano S; Matsumoto Y; Tsuzuki R; Yanagisawa I
    Arch Int Pharmacodyn Ther; 1994; 327(3):330-43. PubMed ID: 7848015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of the novel potassium channel opener UR-8225.
    Tamargo J; Pérez O; Delpón E; García-Rafanell J; Gómez L; Cavalcanti F
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):295-305. PubMed ID: 7475055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.